One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The KEFLEX renal table caps the daily dose in moderate impairment. UCSF uses a different high-dose strategy for selected gram-negative bloodstream infection; Stanford also has a distinct HD regimen.
What to reconcile: The indication and regimen must stay together. Do not average the doses or relabel the bloodstream-infection schedule as a general renal dose.
Open this note and its source referencesKEFLEX limits total daily dose to 1 g at CrCl 30-59 and has insufficient HD adjustment information. UCSF uses higher selected Gram-negative bloodstream-infection doses and supplies an intermittent-HD row.
What to reconcile: Assess infection eligibility, organism susceptibility, patient setting and institutional policy. Keep the complete institutional regimen separate from the label; do not transfer the bloodstream schedule to routine cystitis or children.
Open this note and its source references| Renal range | Source dose recommendation |
|---|---|
| At least 60 | No adjustment |
| 30-59 | No adjustment, but maximum total daily dose 1 g |
| 15-29 | 250 mg every 8 or 12 hours |
| 5-14, not yet on dialysis | 250 mg every 24 hours |
| 1-4, not yet on dialysis | 250 mg every 48 or 60 hours |
The source states that information is insufficient to recommend a hemodialysis adjustment. This label-era table is kept separate from institution-specific high-dose infection regimens.
RDM33-rxlist-cephalexin-C1 · Source locator: Dosage adjustment in renal impairment, Table 1.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=cephalexin&s1=RDM33-rxlist-cephalexin&h1=290a34fe40ef7e83dc7202d891da93baf84ac058b60aa1ba185f779fc817620d